Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 12% | 8.2% | 15.1% |
| Success rate | 100% | 68% | 82% |
| Transactions |
1
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Operating Officer, Chief Medical Officer | Provention Bio Inc | July 1, 2017 - |
| Chief Medical Officer | Global Blood Therapeutics Inc | May 1, 2014 - Oct. 24, 2016 |
Search